Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuo Otsuka

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Internal Medicine (Tokyo, Japan)|November 2, 2011
A case of adult T cell leukemia/lymphoma presenting as severe tracheal stenosisKengo Otsuka, Koji Kuronuma, Mitsuo Otsuka, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Efficacy and safety of nivolumab and ipilimumab with or without chemotherapy for unresectable non-small cell lung cancer: a multicenter retrospective observational studyToshiyuki Sumi, Yutaro Nagano, Keiki Yokoo, et al.
Japanese Journal of Clinical Oncology|May 7, 2025
Efficacy of nivolumab + ipilimumab ± chemotherapy versus pembrolizumab + chemotherapy in patients with PD-L1-negative non-small cell lung cancer (START001 PART-B): a multicenter retrospective observational studyYutaro Nagano, Mamoru Takahashi, Toshiyuki Sumi, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Internal Medicine (Tokyo, Japan)|November 2, 2011
A case of adult T cell leukemia/lymphoma presenting as severe tracheal stenosisKengo Otsuka, Koji Kuronuma, Mitsuo Otsuka, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Efficacy and safety of nivolumab and ipilimumab with or without chemotherapy for unresectable non-small cell lung cancer: a multicenter retrospective observational studyToshiyuki Sumi, Yutaro Nagano, Keiki Yokoo, et al.
Japanese Journal of Clinical Oncology|May 7, 2025
Efficacy of nivolumab + ipilimumab ± chemotherapy versus pembrolizumab + chemotherapy in patients with PD-L1-negative non-small cell lung cancer (START001 PART-B): a multicenter retrospective observational studyYutaro Nagano, Mamoru Takahashi, Toshiyuki Sumi, et al.
Pageof 7